亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

上海富蔗化工有限公司  

醫(yī)藥中間體 農(nóng)藥中間體

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:楊陽
  • 電話:021-66402541,66402542
  • 傳真:021-66402542
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
舒他西林
單價 面議對比
詢價 暫無
發(fā)貨 上海付款后3天內(nèi)
過期 長期有效
更新 2021-04-19 15:31
 
詳細(xì)信息
中文名稱:舒他西林中文同義詞:碸胺米西林;舒他西林;青霉礬氨芐西林;舒巴坦氨芐西林;優(yōu)立新;(+)-羥甲基-(2S,5R,6R)-6-[(R)-(2-氨基-2-苯乙酰氨基)]-3,3-二甲基-7-氧代-4-硫雜-1-氮雜雙環(huán)[3.2.0]正庚烷-2-羧酸酯(2S,5R)-3,3-二甲基-7-氧代-4-硫雜-1-氮雜雙環(huán)[3.2.0]正庚烷-2-羧酸酯S,S-二氧化物;舒他西林堿;舒他西林EP標(biāo)準(zhǔn)品英文名稱:Sultamicillin英文同義詞:4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-,[[(3,3-dimethyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl)carbonyl]oxy]methylester,[2S-[2a(2R*,5S*),5a,6b(S*)]]-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacChemicalbookid,6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-,[[(3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl)carbonyl]oxy]methylester,S,S-dioxide,[2S-[2a(2R*,5S*),5a,6b(S*)]]-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-,[[[(2S,5R)-3,3-dimethyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]oxy]methylester,(2S,5R,6R)-(9CI);CP49952;UnacidPD;VD1827;SULTAMICILLINbase;SULTAMICILLINCAS號:76497-13-7分子式:C25H30N4O9S2分子量:594.66
©2025 上海富蔗化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:15355  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |